London's Pulse: Medical Officer of Health reports 1848-1972

View report page

Poplar 1914

[Report of the Medical Officer of Health for Poplar, Metropolitan Borough]

This page requires JavaScript

211
If 14 samples per week were taken, two in each Inspector's district,
this would mean 728 per annum (which would allow for samples on
delivery at Institutions), and would be at the rate of 4.5 samples per
1,000 inhabitants. A report of the Local Government Board states:
"In London one sample was analysed for every 179 persons, being at the
rate of 5.6 per thousand of the population of 1911."
Expenditure.
Present.
The Public Analyst's salary and emoluments at the present time are
£150 per annum for 250 samples, 7s. 6d. for each extra sample, and £40
in lieu of laboratory. With a minimum number of seven samples per
week this gives a total cost of £233 per annum. It will be seen that the
first 250 samples are analysed at the rate of 12s. per sample.
Whole Time Appointment.
Salaries, Rent, etc.
Should the Council resolve to appoint a whole time analyst and to
establish a laboratory within the Borough, providing that not one of the
existing buildings has suitable accommodation, premises would have to
be provided, with a probable rent and expense as follows:—
Salary of Public Analyst a young man at a commencing
salary of say £300
Laboratory Assistant (improver) 52
Rent and Taxes 100
Light, Water and Chemicals 50
£502
Competency of Analyst.
Under Sub-section 5(3) of the Sale of Food and Drugs Act, 1899,
the Local Government Board on the 7th March, 1900, made a Regulation
as to Competency of Analysts, and in a letter of the 8th March, 1900, as
to proof of skill, state: "the Board may state that it would accord with
their existing practice to accept as sufficient documentary evidence of
the requisite qualification under the Acts, the diploma of fellowship or
associateship of the Institute of Chemistry of Great Britain and Ireland,
together with the certificate granted by the Institute after an examination,
conducted by them on lines approved by the Board, in therapeutics,
pharmacology, and microscopy."
o